Cargando…
GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis
Tideglusib(®), a GSK-3 inhibitor, was initially tested for the treatment of Alzheimer’s disease. However, a recent report has suggested its potential off-label use for the treatment of dental cavities. Even if this effect is not yet confirmed, this off-label use can have significant public/dental he...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330321/ https://www.ncbi.nlm.nih.gov/pubmed/30666199 http://dx.doi.org/10.3389/fphar.2018.01495 |